Q1 2026 Earnings Call Transcript August 19, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.26, ...

Medtronic PLC (MDT) reports robust growth across key segments, raises full-year EPS guidance, and outlines strategic ...

Medtronic (MDT) recently reported its Q1 FY2026 earnings, showing an increase in sales to $8,578 million, while net income ...

Truist raised the firm’s price target on Medtronic (MDT) to $96 from $92 and keeps a Hold rating on the shares. The company’s in-line Q1 organic ...

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...

Medtronic (MDT) stock in focus as the company raises FY2025 earnings outlook amid Q1 outperformance and reduced tariff impact ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

FQ1 results and guidance update did not spark a rally in the share price. Still, they did affirm a robust outlook that ...

Medtronic develops and manufactures a wide range of medical devices, including implantable cardiac pacemakers, heart valves, neurostimulation systems, insulin pumps, and surgical robotics platforms.

The medical device company posted revenue of $8.58 billion in the period, also beating Street forecasts. Eleven analysts surveyed by Zacks expected $8.37 billion. Medtronic expects full-year earnings ...

Medtronic has agreed to not only expand the size of its board of directors, but to also task it with taking a closer look at ...

In the first quarter of fiscal year 2026, Medtronic saw growth in its overall revenue and neuroscience portfolio, according to financial results posted Aug. 19. Five things to know: 1. Total revenue ...